Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure

Yifei Zhong, Yingwei Wu, Ruijie Liu, Yueyi Deng, Sandeep K. Mallipattu, Paul E. Klotman, Peter Y. Chuang, John C. He

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Retinoic acid decreases proteinuria and glomerulosclerosis in several animal models of kidney disease by protecting podocytes from injury. Our recent in vitro studies suggest that all-trans retinoic acid induces podocyte differentiation by activating the retinoic acid receptor-α (RARα)/cAMP/PKA/CREB pathway. When used in combination with all-trans retinoic acid, an inhibitor of phosphodiesterase 4 further enhanced podocyte differentiation by increasing intracellular cAMP. Additionally, we found that Am580, a specific RARα agonist, has similar renal protective effects as all-trans retinoic acid in a rederived colony of HIV-1 transgenic mice with rapidly progressive renal failure (HIV-Tg) that mimics human HIV-associated nephropathy. Treatment with either the inhibitor of phosphodiesterase 4, roflumilast, or Am580 significantly reduced proteinuria, attenuated kidney injury, and improved podocyte differentiation in these HIV-Tg mice. Additional renal protective effects were found when roflumilast was combined with Am580. Consistent with the in vitro data, glomeruli from HIV-Tg mice treated with both Am580 and roflumilast had more active phosphorylated CREB than with either agent alone. Thus, phosphodiesterase 4 inhibitors could be used in combination with RARα agonists to provide additional renal protection.

Original languageEnglish
Pages (from-to)856-864
Number of pages9
JournalKidney International
Volume81
Issue number9
DOIs
StatePublished - 1 May 2012

Keywords

  • HIV nephropathy
  • collapsing glomerulopathy
  • glomerular disease
  • podocyte
  • signaling

Fingerprint

Dive into the research topics of 'Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure'. Together they form a unique fingerprint.

Cite this